Incliva

Noticias

INCLIVA is on the up in 2017: the institution continues to grow and has 182 active research projects

INCLIVA is on the up in 2017: the institution continues to grow and has 182 active research projects
Ana Lluch and Carlos Simón join INCLIVA’s Board of Trustees
Published on 21/12/2017.View more »

The activation mechanism of the Hedgehog pathway involved in rhabdomyosarcoma, a type of childhood cancer, has been...

Identifican el mecanismo de activación de la vía Hedgehog implicada en el rabdomiosarcoma, un tipo de cáncer infantil
Scientists observe in experimental animal models that cells without the appropriate ligands do not form tumors and tumor cell growth is very limited.  
Published on 08/11/2017.View more »

INCLIVA patents a new prosthetic implant in collaboration with the Polytechnic University of Valencia

Se patenta un nuevo implante protésico con la colaboración de INCLIVA-UV
A new prosthetic implant has been designed which stands out because its implantation is safer
Published on 02/10/2017.View more »

The INCLIVA Anesthesia research group obtains the AENOR quality seal

El grupo de investigación en Anestesia de INCLIVA obtiene el sello de calidad AENOR
The Anesthesia Research Group obtains ISO 9001:2015 accreditation
Published on 16/09/2017.View more »

Valencian researchers demonstrate the ability to change the structure and connectivity of interneurons in the adult...

Investigadores valencianos demuestran la capacidad de cambio de la estructura y conectividad de las interneuronas en el cerebro adulto
Researchers from INCLIVA and the University of Valencia show that the structure and connectivity of interneurons in the adult brain, the communication bridge between neurons, have the capacity to change.    
Published on 02/09/2017.View more »

INCLIVA researchers develop a diagnostic prognosis kit for septic shock

Investigadores de INCLIVA desarrollan un kit diagnóstico-pronóstico del “shock” séptico
Researchers from INCLIVA develop a diagnostic prognostic kit for septic shock called ‘HistShock’ which will reduce the number of deaths, currently more than 5 million per year, caused by sepsis.  
Published on 07/08/2017.View more »